Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Acquisitions (2020 - 2024)

Historic Acquisitions for Standard Biotools (LAB) over the last 3 years, with Q4 2024 value amounting to -$278.6 million.

  • Standard Biotools' Acquisitions changed N/A to -$278.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Standard Biotools' Acquisitions is -$278.6 million.
  • Standard Biotools' Acquisitions' 5-year high stood at $280.0 million during Q1 2024, with a 5-year trough of -$278.6 million in Q4 2024.